• WELL Health posted Q2-2026 revenue of $400.4 million, up 12% year over year; net loss was $7.8 million.
• Adjusted EBITDA (non-IFRS) slipped 3% to $48.1 million, due to a $9.7 million Circle Medical deferrals benefit that lifted Q2-2025.
• Canadian Patient Services revenue jumped 32% to $151.6 million; total patient visits rose 19% to 2,000,000.
• Closed OID Group, UnionMD acquisitions, lifting the Canadian clinic network to 275 clinics; issued $150 million 6.875% senior unsecured notes due 2031.
• Raised 2026 guidance to revenue of $1.58 billion-$1.65 billion; lifted adjusted EBITDA (non-IFRS) outlook to $185 million-$195 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WELL Health Technologies Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608061600NEWSFILECNPR____20260806_308425_1) on August 06, 2026, and is solely responsible for the information contained therein.